Trials are continuing with 1181 alone, and in combination with balstilimab, with expanded cohorts, in microsatellite stable colorectal cancer, microsatellite stable endometrial cancer, non...
雄关漫道真如铁 而今迈步从头越
要有比较数据才能定好坏吧。
1181 2个cr 5个pr, 对应50多个实验患者感觉orr并不是很高。好在哪儿啊?副作用少+低表达患者也有效?